Previous 10 | Next 10 |
The following slide deck was published by Prestige Consumer Healthcare Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Prestige Consumer Healthcare Inc. 2021 Q1 - Results - Earnings Call Presentation
Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) traded today at $58.71, eclipsing its 52-week high. This new high was reached on approximately average trading volume as 185,000 shares traded hands, while the average 30-day volume is approximately 220,000 shares. Over the past year...
Prestige Consumer Healthcare (NYSE:PBH): FQ1 GAAP EPS of $1.14 beats by $0.27. Revenue of $269.2M (+17.4% Y/Y) beats by $36.79M. Company raised FY 21 forecast: revenue of $1,045M or more from prior range of $957M to $962M; Adjusted EPS of $3.90 or more from prior range of $3.58 or more. Press...
Revenue was $269.2 Million in Q1, up 17.3% versus Prior Year Record Diluted EPS of $1.14 in Q1, up 32.5% versus Prior Year Net Cash Provided by Operating Activities of $69.3 million and Free Cash Flow of $67.8 Million for First Quarter Fiscal 2022 Raising Full-Year Fiscal 2022...
Prestige Consumer Healthcare Inc. (NYSE:PBH) traded today at a new 52-week high of $53.88. This new high was reached on below average trading volume as 73,000 shares traded hands, while the average 30-day volume is approximately 225,000 shares. Prestige Consumer Healthcare Inc. (NYSE:PBH...
Prestige Consumer Healthcare (PBH) has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands.The acquisition of TheraTears will further enhance Prestige’s eye care portfolio and generate additional long-term growth opportunities fo...
TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige“ or the “Company”) today announced that it has completed the previously announced acquisition of TheraTears and other over-the-counter consumer br...
Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) traded today at $52.95, eclipsing its 52-week high. Approximately 52,000 shares have changed hands today, as compared to an average 30-day volume of 229,000 shares. Prestige Consumer Healthcare is an American company that distributes...
Prestige Consumer Healthcare (PBH) inks an agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Company LLC ((Akorn)) for $230 million in cash.The consumer product portfolio acquired from Akorn features the TheraTears eye c...
Acquisition adds TheraTears brand to Company’s leading eye care portfolio Acquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basis Transaction expected to close during fiscal 2Q TARRYTOWN, N.Y., May 27, 202...
News, Short Squeeze, Breakout and More Instantly...
Prestige Consumer Healthcare Inc. Company Name:
PBH Stock Symbol:
NYSE Market:
Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding Currency Diluted EPS of $1.02 for Q2, ahead of expectations Reduced Debt by $35 million in Q2 and Achieved Leverage Ratio of 3.7x Reaffirming Full-Year Fiscal 2023 Revenue an...
TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November 3, 2022 before the opening of the market. The Company will host a conference call to discu...
Presentation Times and Weblinks Released for Over 100 Presenting Companies Wednesday and Thursday, September 21-22, 2022 NEW YORK, NY / ACCESSWIRE / September 20, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day September Small-...